Truist maintains Lockheed Martin stock Buy rating, $579 target
Truist Securities maintained their positive stance on Lockheed Martin stock (NYSE:LMT), reiterating a Buy rating and a price target of $579.00. The firm's analysis suggests that recent market ...
Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
As previously reported, Truist initiated coverage of Larimar Therapeutics (LRMR) with a Buy rating and $18 price target Despite “promising” ...
Larimar Therapeutics initiated with a Buy at Truist
Truist analyst Joon Lee initiated coverage of Larimar Therapeutics (LRMR) with a Buy rating and $18 price target Invest with Confidence: Follow ...